JP2014533241A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014533241A5 JP2014533241A5 JP2014539111A JP2014539111A JP2014533241A5 JP 2014533241 A5 JP2014533241 A5 JP 2014533241A5 JP 2014539111 A JP2014539111 A JP 2014539111A JP 2014539111 A JP2014539111 A JP 2014539111A JP 2014533241 A5 JP2014533241 A5 JP 2014533241A5
- Authority
- JP
- Japan
- Prior art keywords
- patent document
- application publication
- patent application
- insulin
- prior
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161552246P | 2011-10-27 | 2011-10-27 | |
| US61/552,246 | 2011-10-27 | ||
| PCT/US2012/062423 WO2013063572A1 (en) | 2011-10-27 | 2012-10-29 | Ultra-concentrated rapid-acting insulin analogue formulations |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014533241A JP2014533241A (ja) | 2014-12-11 |
| JP2014533241A5 true JP2014533241A5 (enExample) | 2015-12-17 |
Family
ID=48168643
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014539111A Pending JP2014533241A (ja) | 2011-10-27 | 2012-10-29 | 超濃縮速効型インスリン類似体製剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9908925B2 (enExample) |
| EP (1) | EP2771026A4 (enExample) |
| JP (1) | JP2014533241A (enExample) |
| KR (1) | KR20150021011A (enExample) |
| CN (1) | CN104010652A (enExample) |
| AU (1) | AU2012328407A1 (enExample) |
| BR (1) | BR112014010139A2 (enExample) |
| IN (1) | IN2014CN03888A (enExample) |
| SG (1) | SG11201401835VA (enExample) |
| WO (1) | WO2013063572A1 (enExample) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2694418T3 (es) * | 2012-11-05 | 2018-12-20 | Case Western Reserve University | Análogos de insulina de cadena sencilla de acción prolongada |
| BR112016016290A2 (pt) | 2014-01-13 | 2017-10-03 | Thermalin Diabetes Llc | Composições farmacêuticas de insulina de ação rápida, conjunto de infusão, sistema de conjunto de infusão e usos de análogos monoméricos ou diméricos de insulina |
| AR099569A1 (es) | 2014-02-28 | 2016-08-03 | Novo Nordisk As | Derivados de insulina y los usos médicos de estos |
| EP3223844A4 (en) * | 2014-10-20 | 2018-08-15 | Case Western Reserve University | Halogenated insulin analogues of enhanced biological potency |
| SG10201809428UA (en) * | 2014-11-21 | 2018-11-29 | Merck Sharp & Dohme | Insulin receptor partial agonists |
| WO2016105545A2 (en) * | 2014-12-24 | 2016-06-30 | Case Western Reserve University | Insulin analogues with enhanced stabilized and reduced mitogenicity |
| JP2018531901A (ja) | 2015-08-25 | 2018-11-01 | ノヴォ ノルディスク アー／エス | 新規インスリン誘導体及びその医学的使用 |
| US11352406B2 (en) | 2015-08-25 | 2022-06-07 | Novo Nordisk A/S | Insulin derivatives and the medical uses hereof |
| EP3341402A1 (en) | 2015-08-25 | 2018-07-04 | Novo Nordisk A/S | Novel insulin derivatives and the medical uses hereof |
| WO2017070617A1 (en) * | 2015-10-21 | 2017-04-27 | Case Western Reserve University | Diol-modified insulin analogues containing a glucose-regulated conformational switch |
| KR20180097517A (ko) | 2015-12-23 | 2018-08-31 | 케이스 웨스턴 리저브 유니버시티 | 매우 안정된 인슐린 유사체의 중합체 용융물 내 캡슐화 |
| SG11202106167XA (en) * | 2018-12-11 | 2021-07-29 | Sanofi Sa | Insulin conjugates |
| CA3159114A1 (en) | 2019-12-11 | 2021-06-17 | Frantisek Hubalek | Novel insulin analogues and uses thereof |
| WO2024194897A1 (en) * | 2023-03-22 | 2024-09-26 | Council Of Scientific And Industrial Research An Indian Registered Body Incorporated Under The Regn. Of Soc. Act (Act Xxi Of 1860) | A glycation resistant insulin polypeptide and a method of preparing the same thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4992418A (en) * | 1987-07-17 | 1991-02-12 | Mount Sinai School Of Medicine | Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin |
| JPH03506023A (ja) | 1988-07-20 | 1991-12-26 | ノボ ノルデイスク アクツイエセルスカプ | ポリペプチド |
| US5474978A (en) | 1994-06-16 | 1995-12-12 | Eli Lilly And Company | Insulin analog formulations |
| US20030104981A1 (en) * | 1995-11-03 | 2003-06-05 | Jelena Mandic | Human insulin analogues |
| DE10114178A1 (de) | 2001-03-23 | 2002-10-10 | Aventis Pharma Gmbh | Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität |
| EP1453860A2 (en) | 2001-12-02 | 2004-09-08 | Novo Nordisk A/S | Novel glucose-dependant insulins |
| US7317000B2 (en) * | 2001-12-02 | 2008-01-08 | Novo Nordisk A/S | Glucose-dependent insulins |
| CA2522818A1 (en) * | 2003-03-11 | 2004-09-23 | Soren Ostergaard | Pharmaceutical preparations comprising acid-stabilised insulin |
| SE0401942D0 (sv) * | 2004-07-28 | 2004-07-28 | Lipopeptide Ab | New antimicrobial peptide complexes |
| WO2006018450A2 (en) | 2004-08-20 | 2006-02-23 | Novo Nordisk A/S | Pharmaceutically active insulin receptor-modulating molecules |
| ES2554773T3 (es) * | 2006-10-04 | 2015-12-23 | Case Western Reserve University | Insulina y análogos de la insulina resistentes a la fibrilación |
| CA2703830A1 (en) * | 2007-11-20 | 2009-05-28 | Ambrx, Inc. | Modified insulin polypeptides and their uses |
| KR20120129875A (ko) | 2008-07-31 | 2012-11-28 | 케이스 웨스턴 리저브 유니버시티 | 염소화 아미노산을 갖는 인슐린 유사체 |
| EP2318432B1 (en) * | 2008-07-31 | 2015-09-02 | Case Western Reserve University | Halogen-stabilized insulin |
| WO2010080606A1 (en) * | 2008-12-19 | 2010-07-15 | Indiana University Research And Technology Corporation | Insulin analogs |
-
2012
- 2012-10-29 BR BR112014010139A patent/BR112014010139A2/pt not_active IP Right Cessation
- 2012-10-29 AU AU2012328407A patent/AU2012328407A1/en not_active Abandoned
- 2012-10-29 KR KR20147011706A patent/KR20150021011A/ko not_active Withdrawn
- 2012-10-29 CN CN201280064561.7A patent/CN104010652A/zh active Pending
- 2012-10-29 JP JP2014539111A patent/JP2014533241A/ja active Pending
- 2012-10-29 US US14/354,667 patent/US9908925B2/en not_active Expired - Fee Related
- 2012-10-29 EP EP12843655.7A patent/EP2771026A4/en not_active Withdrawn
- 2012-10-29 WO PCT/US2012/062423 patent/WO2013063572A1/en not_active Ceased
- 2012-10-29 SG SG11201401835VA patent/SG11201401835VA/en unknown
-
2014
- 2014-05-23 IN IN3888CHN2014 patent/IN2014CN03888A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014533241A5 (enExample) | ||
| JP2014519662A5 (enExample) | ||
| JP2014513484A5 (enExample) | ||
| JP2013517798A5 (enExample) | ||
| JP2014525291A5 (enExample) | ||
| CY1123270T1 (el) | Υποκατεστημενες ενωσεις βενζαλδεϋδης και μεθοδοι για τη χρηση τους στην αυξηση της οξυγονωσης των ιστων | |
| JP2013540292A5 (enExample) | ||
| JP2014532727A5 (enExample) | ||
| JP2014519854A5 (enExample) | ||
| JP2014520155A5 (enExample) | ||
| JP2013519136A5 (enExample) | ||
| JP2015522045A5 (enExample) | ||
| EA201490654A1 (ru) | Новые ингибиторы вирусной репликации | |
| JP2013079282A5 (enExample) | ||
| JP2012074699A5 (enExample) | ||
| JP2016506366A5 (enExample) | ||
| JP2016513069A5 (enExample) | ||
| JP2013214010A5 (enExample) | ||
| JP2011105738A5 (enExample) | ||
| JP2011528248A5 (enExample) | ||
| JP2013532130A5 (enExample) | ||
| JP2018525453A5 (enExample) | ||
| JP2017511377A5 (enExample) | ||
| JP2012094862A5 (enExample) | ||
| JP2014508098A5 (enExample) |